BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10951397)

  • 21. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.
    Puxeddu E; Moretti S; Giannico A; Martinelli M; Marino C; Avenia N; Cristofani R; Farabi R; Reboldi G; Ribacchi R; Pontecorvi A; Santeusanio F
    Eur J Endocrinol; 2003 May; 148(5):505-13. PubMed ID: 12720532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population.
    Lee S; Hong SW; Moon WC; Oh MR; Lee JK; Ahn CW; Cha BS; Kim KR; Lee HC; Lim SK
    Thyroid; 2005 Mar; 15(3):259-66. PubMed ID: 15785245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene rearrangements in radiation-induced thyroid carcinogenesis.
    Rabes HM
    Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma.
    Elisei R; Romei C; Soldatenko PP; Cosci B; Vorontsova T; Vivaldi A; Basolo F; Cherstvoy ED; Pinchera A; Pacini F
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):131-6. PubMed ID: 10931090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
    Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
    Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of wild-type c-RET and zero prevalence of RET/PTC rearrangements are associated with papillary thyroid cancer (PTC) in Kuwait.
    El-Abdallah AA; Junaid TA
    Exp Mol Pathol; 2011 Feb; 90(1):61-5. PubMed ID: 20950609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
    Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
    Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunostaining and RT-PCR: different approaches to search for RET rearrangements in patients with papillary thyroid carcinoma.
    Rebelo S; Domingues R; Catarino AL; Mendonça E; Santos JR; Sobrinho L; Bugalho MJ
    Int J Oncol; 2003 Oct; 23(4):1025-32. PubMed ID: 12963982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RET/PTC rearrangement occurring in primary peritoneal carcinoma.
    Flavin R; Jackl G; Finn S; Smyth P; Ring M; O'Regan E; Cahill S; Unger K; Denning K; Jinghuan Li ; Aherne S; Tallini G; Gaffney E; O'Leary JJ; Zitzelsberger H; Sheils O
    Int J Surg Pathol; 2009 Jun; 17(3):187-97. PubMed ID: 19147513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of level II-V lymph node involvement in RET/PTC positive papillary thyroid carcinoma.
    Wang YL; Zhang RM; Luo ZW; Wu Y; Du X; Wang ZY; Zhu YX; Li DS; Ji QH
    Eur J Surg Oncol; 2008 Jan; 34(1):77-81. PubMed ID: 17954023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma.
    Ciampi R; Giordano TJ; Wikenheiser-Brokamp K; Koenig RJ; Nikiforov YE
    Endocr Relat Cancer; 2007 Jun; 14(2):445-52. PubMed ID: 17639057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
    Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1.
    Musholt TJ; Brehm C; Hanack J; von Wasielewski R; Musholt PB
    J Surg Res; 2006 Mar; 131(1):15-25. PubMed ID: 16256137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
    Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.
    Nikiforova MN; Caudill CM; Biddinger P; Nikiforov YE
    Int J Surg Pathol; 2002 Jan; 10(1):15-22. PubMed ID: 11927965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.
    Cheung CC; Carydis B; Ezzat S; Bedard YC; Asa SL
    J Clin Endocrinol Metab; 2001 May; 86(5):2187-90. PubMed ID: 11344225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.